Sign in

Constance Moore

Director at Civeo
Board

About Constance B. Moore

Constance B. Moore, age 69, is an independent director of Civeo Corporation (CVEO) who has served on the board since 2014; she is Audit Committee Chair and a member of the Compensation Committee, and is designated an audit committee financial expert . She holds an MBA from UC Berkeley (Haas) and a bachelor’s degree from San Jose State University, and has 40+ years in real estate, including public company CEO and director experience .

Past Roles

OrganizationRoleTenureCommittees/Impact
BRE Properties, Inc.President & CEO; previously President & COO; DirectorCEO Jan 2005–Apr 2014; COO Jan–Dec 2004; Director Sep 2002–Apr 2014Led a public REIT; significant public company leadership and real estate operating experience .
Security Capital Group & AffiliatesManaging DirectorPrior to joining BRE; Exec roles 1993–2002Held several executive positions; co‑chairman & COO of Archstone Communities Trust during 1993–2002 period .
National Association of Real Estate Investment Trusts (NAREIT)Chair2009Industry leadership recognition .

External Roles

Company/InstitutionRoleTenureCommittees/Notes
TriPointe Homes (NYSE: TPH)Director; Chair of Compensation Committee; Audit Committee memberSince Jul 2014Compensation chair; audit member .
Healthcare Realty Trust (NYSE: HR)Director; Interim President & CEODirector since Mar 2022; Interim CEO since Nov 2024Currently does not serve on standing committees while interim CEO .
Columbia Property Trust (NYSE: CXP)Director; Chair of Board in 2021Nov 2017–Dec 2021 (acquired Dec 2021)Board leadership; acquisition ended tenure .
Fisher Center for Real Estate & Urban Economics, UC BerkeleyPolicy Advisory Board ChairCurrentAcademic policy leadership .
Haas School of Business Advisory Board, UC BerkeleyEmeritus MemberCurrentGovernance advisory .
Urban Land Institute (ULI)Governor & Lifetime TrusteeCurrentIndustry governance .
Bridge Housing Corp; San Jose State University Tower BoardDirector2014–2024 (Bridge); 2007–2024 (SJSU Tower)Nonprofit governance .

Board Governance

  • Independence: The board determined all directors except the CEO are “independent” under NYSE standards; Moore is independent .
  • Committee assignments: Audit Committee Chair; Compensation Committee member; she is financially literate and qualifies as an audit committee financial expert .
  • Meetings and engagement: In 2024, the board met 6 times; Audit Committee 7; Compensation Committee 7; ESG&N Committee 5; Finance & Investment Committee 2. The proxy reports 100% board meeting attendance by each director and 100% committee attendance for directors except one director who attended 87.5% of his/her committee meetings (individual not identified) .
  • Executive sessions: Independent directors meet in executive session, generally at each board and committee meeting; sessions are presided over by the independent Chair or committee chairs .
  • Risk oversight: Audit oversees financial reporting, internal controls, litigation, cyber/AI; Compensation oversees executive compensation and succession; ESG&N oversees independence, conflicts and governance; Finance & Investment oversees strategic financial policies .
  • Hedging/pledging: Directors are prohibited from hedging, short sales, trading options/derivatives, and pledging or margining CVEO securities .

Fixed Compensation

ComponentAmountNotes
Annual Board Cash Retainer$75,000Standard non‑employee director retainer .
Audit Committee Chair Cash Retainer$27,500Chair fee .
Compensation Committee Member Cash Retainer$13,000Member fee .
Total Fees Earned/Paid in Cash (2024)$115,500As reported for Moore .
Meeting FeesNone disclosedNo per‑meeting fees disclosed .
Chair of the Board RetainerNot applicableChair retainer applies to board chair only .

Performance Compensation

ComponentGrant ValueTerms
Annual Equity Retainer (Restricted Shares or Deferred Shares)$125,000Valued at grant‑date closing price; vests on earlier of one year from grant or next AGM; directors may elect deferred shares settling at separation from service .
Stock Awards (2024 reported value)$125,012Aggregate grant date fair value under ASC 718 for Moore .
Options/PSUsNone disclosed for directorsDirector equity is time‑based restricted shares/deferred shares; no options or performance share units disclosed for directors .

Other Directorships & Interlocks

  • Current public company boards: TriPointe Homes (TPH) and Healthcare Realty Trust (HR) .
  • Prior public boards: Columbia Property Trust (CXP, acquired Dec 2021) and BRE Properties, Inc. .
  • Interlocks/conflicts: The proxy discloses no related‑party transactions requiring Item 404(a) disclosure since the beginning of the last fiscal year; ESG&N Committee oversees independence and conflicts .
  • Consultant independence (compensation governance): Mercer advises the Compensation Committee on director compensation; the Committee assessed Mercer’s independence and found no conflicts in 2024 .

Expertise & Qualifications

  • Audit committee financial expert; financially literate, with accounting/reporting insight .
  • 40+ years’ real estate industry experience; public company CEO and public company director experience across multiple REITs and homebuilders .
  • Education: MBA (UC Berkeley, Haas); bachelor’s degree (San Jose State University) .
  • International, governance, and ESG experience through board roles and industry organizations .

Equity Ownership

MetricValue
Current Holdings (as of Mar 17, 2025)40,338 shares
Target Ownership (5× annual retainer)21,552 shares
Guideline ComplianceYes
Unvested Restricted Shares (12/31/2024)5,051 shares
Shares Outstanding (Record Date, Mar 17, 2025)13,549,417 shares
Ownership as % of Shares Outstanding~0.30% (40,338 ÷ 13,549,417)
Hedging/Pledging StatusProhibited by policy

Governance Assessment

  • Strengths: Independent director with deep real estate and public company governance expertise; Audit Chair and designated financial expert; strong engagement with board and committee activities in a board that reports 100% attendance at board meetings; robust anti‑hedging/anti‑pledging policy; and full compliance with stock ownership guidelines indicating alignment with shareholders .
  • Compensation alignment: Director pay structure balanced between modest cash retainers and annual time‑based equity; no options or performance‑contingent equity for directors; use of an independent consultant for periodic benchmarking .
  • Conflicts/related parties: No related‑party transactions disclosed for the period; ESG&N Committee and the Code of Conduct enforce conflict oversight .
  • Watchpoints: Concurrent interim CEO role at Healthcare Realty Trust increases external time demands; CVEO’s nomination criteria explicitly consider number of other public boards and time/availability, mitigating risk through ongoing ESG&N oversight; the proxy notes one unidentified director had sub‑100% committee attendance (87.5%)—no indication this was Moore .
  • Shareholder sentiment: Say‑on‑Pay approval in 2024 was 96.7%, supportive of CVEO’s compensation governance environment .

RED FLAGS: None disclosed regarding related‑party transactions, hedging/pledging, or director‑specific attendance shortfalls; monitor time commitments due to interim CEO role elsewhere and continue to review cross‑company relationships though none are disclosed as related parties .